GENOTECH CORP. Logo

GENOTECH CORP.

A biotech firm offering gene synthesis, genome analysis, and biopharmaceutical products globally.

066830 | KO

Overview

Corporate Details

ISIN(s):
KR7066830001
LEI:
Country:
South Korea
Address:
대전광역시 유성구 가정북로 26-69, 대전광역시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Genotech Corp. is a South Korea-based biotechnology company that engages in the production and sale of pharmaceutical and biological products. The company's core activities include providing products and services for gene synthesis, genome analysis, and biopharmaceuticals. It also manufactures basic pharmaceutical substances and biological agents, offering related technical and academic services to both domestic and international markets.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-19 00:00
Regulatory News Service
기업설명회(IR)개최결과
Korean 6.6 KB
2025-06-09 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.3 KB
2025-03-31 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-03-26 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 89.5 KB
2025-03-24 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 19.9 KB
2025-03-14 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 320.9 KB
2025-03-11 00:00
Audit Report / Information
감사보고서제출
Korean 9.7 KB
2025-03-04 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 103.5 KB
2025-02-25 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 11.6 KB
2024-12-06 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2024-11-13 00:00
Report Publication Announcement
기업설명회(IR)개최결과
Korean 6.6 KB
2024-10-30 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.0 KB
2024-09-05 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 57.1 KB
2024-08-16 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 85.7 KB
2024-08-14 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.0 KB

Automate Your Workflow. Get a real-time feed of all GENOTECH CORP. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for GENOTECH CORP.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for GENOTECH CORP. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

AIM ImmunoTech Inc. Logo
Develops immuno-therapeutics for cancers, immune disorders, and viral diseases.
United States of America
AIM
AKANDA CORP. Logo
Cultivates and distributes pharma-quality medical cannabis for patients in legal markets worldwide.
United States of America
AKAN
Akari Therapeutics Plc Logo
A clinical-stage oncology company developing next-gen ADCs for targeted cancer therapy.
United States of America
AKTX
Akebia Therapeutics, Inc. Logo
Developing and commercializing novel, FDA-approved therapeutics for kidney disease.
United States of America
AKBA
Akero Therapeutics, Inc. Logo
A clinical-stage biotech developing therapies for serious metabolic diseases like MASH.
United States of America
AKRO
Alaunos Therapeutics, Inc. Logo
Developing TCR-T cell therapies to treat solid tumors by targeting specific cancer mutations.
United States of America
TCRT
Aldeyra Therapeutics, Inc. Logo
Biotech developing therapies for ocular and systemic immune-mediated inflammation.
United States of America
ALDX
Alector, Inc. Logo
Pioneers immuno-neurology therapies for neurodegenerative diseases like Alzheimer's.
United States of America
ALEC
Aligos Therapeutics, Inc. Logo
Clinical-stage biopharma developing novel oral therapies for liver and viral diseases.
United States of America
ALGS
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark
ALK

Talk to a Data Expert

Have a question? We'll get back to you promptly.